Leading Independent Proxy Advisor ISS Recommends that Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees; REJECTS Apollo’s Arguments and Director Slate
Globenewswire·2025-06-02 11:00
ISS concludes that Apollo “has not presented a compelling case for change”TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, today announced that Institutional Shareholder Services (“ISS”) published a report on May 30, 2025 (the “ISS Report”) recommending that MediPharm shareholders vote the GREEN Proxy or voting instruction form FOR the Company’s nominees ...